By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Blake Insomnia Therapeutics, Inc. 

244, 5th Avenue
Suite A-154
New York  New York  10001  U.S.A.
Phone: 888-612-2905 Fax: n/a


SEARCH JOBS

Blake Insomnia Therapeutics, Inc. is a New York-based pharmaceutical company devoted to improving nighttime and daytime quality of life for people with insomnia. Our patent-pending compound, Zleepax™ (ZLX-1), has demonstrated efficacy without causing side effects identified as the No. 1 problem with current sleep medication. Blake Insomnia completed its reverse merger into NASDAQ OTC in second half of 2015.

YEAR FOUNDED:

2012

LEADERSHIP:

Founder and CEO: Birger Jan Olsen


Key Statistics


Email: help@blakeinsomnia.com
Ownership: Public

Web Site: Blake Insomnia Therapeutics
Employees:
Symbol: BKIT
 



Industry
Biotechnology






Company News
Blake Insomnia Therapeutics (BKIT) Announces Appointment Of Morten Albrechtsen To Its Board Of Directors 6/16/2017 6:54:57 AM
Blake Insomnia Therapeutics (BKIT) Announces Appointment Of Kyle Sarwal And Ajit Johal To Its Board Of Directors 5/25/2017 8:08:30 AM
Blake Insomnia Therapeutics (BKIT) Announces Appointment Of Dr. Eric Leire To Its Board Of Directors 5/10/2017 12:40:49 PM
Blake Insomnia Therapeutics (BKIT) Closes Joint Venture With Sajo Consulting LLC 2/27/2017 8:19:54 AM
Blake Insomnia Therapeutics (BKIT) Enters A Joint Development With Sajo Consulting LLC 2/9/2017 9:01:18 AM
Blake Insomnia Therapeutics (BKIT) Release: Company Seeks Financing For Clinical Trials 1/17/2017 7:00:12 AM
Blake Insomnia Therapeutics (BKIT) Wants To Awaken A Billion Dollar Industry 12/22/2016 7:30:19 AM
//-->